Oxford BioTherapeutics is focused on the development of targeted medicines for oncology. The company uses OGAP®, which it has developed into the world’s largest cancer protein database, to discover novel clinically relevant drug targets and diagnostics.Formed in 2004, OBT is privately held and is based near Oxford, UK.